Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis

Experimental Hematology

Volumn 27, Issue 1, 1999, Pages 75-87

  Innes, Karin M ^a   Szilvassy, Stephen J ^a   Davidson, Heather E ^a   Gibson, Leonie ^a   Adams, Jerry M ^a   Cory, Suzanne ^a  

^a NONE

Author keywords

Bcl 2; Cell survival; Hematopoietic stem cells; Retroviral vector

Indexed keywords

PROTEIN BCL 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL LINEAGE; CELL SURVIVAL; GENETIC TRANSDUCTION; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; T LYMPHOCYTE; VIRUS EXPRESSION;

ANIMALS; BONE MARROW CELLS; CELL LINEAGE; CELL SURVIVAL; CLONE CELLS; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, BCL-2; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; LEUKOCYTES; LYMPHOCYTES; LYMPHOMA; MALE; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-BCL-2; PROVIRUSES; RETROVIRIDAE; TIME FACTORS;

ANIMALIA; SIGANUS; UNIDENTIFIED RETROVIRUS;

EID: 0033020472     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00015-0     Document Type: Article

References (73)

1. Dunbar C.E., Emmons R.V. Gene transfer into hematopoietic progenitor and stem cells. progress and problems Stem Cells. 12:1994;563.
2. Nienhuis A.W. Gene transfer into hematopoietic stem cells. Blood Cells. 20:1994;141.
3. Havenga M., Hoogerbrugge P., Valerio D., van Es H.H.G. Retroviral stem cell gene therapy. Stem Cells. 15:1997;162.
4. Salmons B., Saller R.M., Baumann J.G., Günzburg W.H. Construction of retroviral vectors for targeted delivery and expression of therapeutic genes. Leukemia. 9:1995;S53.
5. Spangrude G.J., Johnson G.R. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci USA. 87:1990;7433.
6. Harrison D.E., Lerner C.P. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood. 78:1991;1237.
7. Miller D.G., Adam M.A., Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 10:1990;4239.
8. Szilvassy S.J., Humphries R.K., Lansdorp P.M., Eaves A.C., Eaves C.J. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci USA. 87:1990;8736.
9. Szilvassy S.J., Cory S. Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. Blood. 81:1993;2310.
10. Szilvassy S.J., Cory S. Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood. 84:1994;74.
11. Williams D.A., Lim B., Spooncer E., Longtine J., Dexter T.M. Restriction of expression of an integrated recombinant retrovirus in primary but not immortalized murine hematopoietic stem cells. Blood. 71:1988;1738.
12. Bowtell D.D.L., Johnson G.R., Kelso A., Cory S. Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses. Mol Biol Med. 4:1987;229.
13. Tsujimoto Y., Yunis J., Onorato-Showe L., Erikson J., Nowell P.C., Croce C.M. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science. 224:1984;1403.
14. Cory S. Regulation of lymphocyte survival by the BCL-2 gene family. Annu Rev Immunol. 13:1995;513.
15. Park J.R., Hockenbery D.M. BCL-2, a novel regulator of apoptosis. J Cell Biochem. 60:1996;12.
16. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614.
17. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440.
18. Reed J.C., Miyashita T., Takayama S., Wang H.-G., Sato T., Krajewski S., Aimé-Sempé C., Bodrug S., Kitada S., Hanada M. BCL-2 family proteins. regulators of cell death involved in the pathogenesis of cancer and resistance to therapy J Cell Biochem. 60:1996;23.
19. Hockenbery D.M., Zutter M., Hickey W., Nahm M., Korsmeyer S. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA. 88:1991;6961.
20. Pezzella F., Tse A.G.D., Cordell J.L., Pulford K.A.F., Gatter K.C., Mason D.Y. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol. 137:1990;225.
21. Veis D.J., Sentman C.L., Bach E.A., Korsmeyer S.J. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol. 151:1993;2546.
22. Merino R., Ding L., Veis D.J., Korsmeyer S.J., Nuñez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 13:1994;683.
23. Delia D., Aiello A., Soligo D., Fontanella E., Melani C., Pezzella F., Pierotti M.A., Della Porta G. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood. 79:1992;1291.
24. Porwit-MacDonald A., Ivory K., Wilkinson S., Wheatley K., Wong L., Janossy G. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia. 9:1995;1191.
25. McDonnell T.J., Deane N., Platt F.M., Nuñez G., Jaeger U., McKearn J.P., Korsmeyer S.J. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 57:1989;79.
26. Strasser A., Whittingham S., Vaux D.L., Bath M.L., Adams J.M., Cory S., Harris A.W. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA. 88:1991;8661.
27. Katsumata M., Siegel R.M., Louie D.C., Miyashita T., Tsujimoto Y., Nowell P.C., Greene M.I., Reed J.C. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA. 89:1992;11376.
28. McDonnell T.J., Korsmeyer S.J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature. 349:1991;254.
29. Strasser A., Harris A.W., Cory S. Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene. 8:1993;1.
30. Sentman C.L., Shutter J.R., Hockenbery D., Kanagawa O., Korsmeyer S.J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:1991;879.
31. Strasser A., Harris A.W., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;889.
32. Park J.R., Robertson K., Hickstein D.D., Tsai S., Hockenbery D.M., Collins S.J. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood. 84:1994;440.
33. Naumovski L., Cleary M.L. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood. 83:1994;2261.
34. Lagasse E., Weissman I.L. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med. 179:1994;1047.
35. Strasser A., Harris A.W., Vaux D.L., Webb E., Bath M.L., Adams J.M., Cory S. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol. 166:1990;175.
36. Grez M., Akgun E., Hilberg F., Ostertag W. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci USA. 87:1990;9202.
37. Miller A.D., Rosman G.J. Improved retroviral vectors for gene transfer and expression. Biotechniques. 7:1989;980.
38. Armentano D., Yu S.-F., Kantoff P.W., von Ruden T., Anderson W.F., Gilboa E. Effect of internal viral sequences on the utility of retroviral vectors. J Virol. 61:1987;1647.
39. Cepko C.L., Roberts B.E., Mulligan R.C. Construction and application of a highly transmissible murine retrovirus shuttle vector. Cell. 37:1984;1053.
40. Seliger B., Kollek R., Stocking C., Franz T., Ostertag W. Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines. expression of the mos oncogene Mol Cell Biol. 6:1986;286.
41. Morgenstern J.P., Land H. Advanced mammalian gene transfer. high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line Nucleic Acids Res. 18:1990;3587.
42. Takebe Y., Seiki M., Fujisawa J.-I., Hoy P., Yokota K., Arai K.-I., Yoshida M., Arai N. SRα promoter. an efficient and versatile mammalian cDNA expression system composed of the Simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat Mol Cell Biol. 8:1988;466.
43. Cleary M.L., Smith S.D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:1986;19.
44. De La Luna S., Ortin J. pac genes as efficient dominant marker and reporter gene in mammalian cells. Methods Enzymol. 216:1992;376.
45. Lynch C.M., Miller A.D. Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J Virol. 65:1991;3887.
46. Unkeless J.C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 150:1979;580.
47. Strasser A., Harris A.W., Huang D.C.S., Krammer P.H., Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:1995;6136.
48. Ikuta K., Kina T., McNeil I., Uchida N., Peault B., Chien Y., Weissman I.L. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell. 62:1990;863.
49. Watt S.M., Burgess A.W., Metcalf D. Isolation and surface labeling of murine polymorphonuclear neutrophils. J Cell Physiol. 100:1979;1.
50. Andersson J., Sjoberg O., Moller G. Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol. 2:1972;349.
51. Gough N.M., Kelso A. GM-CSF expression is preferential to multi-CSF (IL-3) expression in murine T lymphocyte clones. Growth Factors. 1:1989;287.
52. Don R.H., Cox P.T., Wainwright B.J., Baher K., Mattick J.S. "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19:1991;4008.
53. Oettinger M.A., Schatz D.G., Gorka C., Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science. 248:1990;1517.
54. Elefanty A.G., Robb L., Birner R., Begley C.G. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. Blood. 90:1997;1435.
55. Grez M., Zörnig M., Nowock J., Ziegler M. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells. J Virol. 65:1991;4691.
56. Bowtell D.D., Cory S., Johnson G.R., Gonda T.J. Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J Virol. 62:1988;2464.
57. Rivière I., Brose K., Mulligan R.C. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA. 92:1995;6733.
58. Hawley R.G., Fong A.Z.C., Burns B.F., Hawley T.S. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med. 176:1992;1149.
59. Apperley J.F., Luskey B.D., Williams D.A. Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells. effect of selectable marker sequences on long-term expression Blood. 78:1991;310.
60. Artlet P., Grannemann R., Stocking C., Friel J., Bartsch J., Hauser H. The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene. 99:1992;249.
61. Perkins A.C., Cory S. Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. EMBO J. 12:1993;3835.
62. Luskey B.D., Rosenblatt M., Zsebo K., Williams D.A. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood. 80:1992;396.
63. Harrison D.E., Astle C.M., Delaittre J.A. Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging. J Exp Med. 147:1978;1526.
64. Mehr R., Fridkis-Hareli M., Abel L., Segel L., Globerson A. Lymphocyte development in irradiated thymuses. dynamics of colonization by progenitor cells and regeneration of resident cells J Theor Biol. 177:1995;181.
65. Kaplan H.S., Brown M.B. A quantitative dose-response study of lymphoid-tumor development in irradiated C57 black mice. J Natl Cancer Inst. 13:1952;185.
66. Baum C., Hegewisch-Becker S., Eckert H.-G., Stocking C., Ostertag W. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol. 69:1995;7541.
67. L and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene. 14:1997;405.
68. O'Reilly L., Huang D.C.S., Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:1996;6979.
69. Mazel S., Burtrum D., Petrie H.T. Regulation of cell division cycle progression by bcl-2 expression. a potential mechanism for inhibition of programmed cell death J Exp Med. 183:1996;2219.
70. Vairo G., Innes K.M., Adams J.M. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene. 13:1996;1511.
71. Matsuzaki Y., Nakayama K.-I., Nakayama K., Tomita T., Isoda M., Loh D.Y., Nakauchi H. Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood. 89:1997;853.
72. Lagasse E., Weissman I.L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteoperosis in op/op mice. Cell. 89:1997;1021.
73. Ogilvy S., Elefanty A.G., Visvader J., Bath M.L., Harris A.W., Adams J.M. Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood. 91:1998;419.